Pfizer/BioNTech PR Highlights Studies On Three Doses Of Pfizer-BioNTech COVID-19 Vaccine In Omicron; Says 'Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant'